Meet 'Milasen': The first-ever drug designed for just one patient

Eight-year-old Mila Makovec was diagnosed with a rare, usually fatal neurological disorder in 2016, but now—thanks to a 'custom' drug that researchers developed specifically for her—many of Mila's symptoms have been halted or reversed, according to a report published Wednesday in the New England Journal of Medicine.

Read More
Advisory Board Insight

5 ways to feel less overwhelmed. (Hint: The answer isn't just to work more hours.)

When you feel overwhelmed, you may assume you just need to work harder to clear out your to-do list—but that's not always the right approach, Rebecca Zucker, an executive coach, writes for Harvard Business Review. Here are five ways you can alleviate stress without working longer hours.

The right way to taper patients off of opioids, according to HHS

HHS on Thursday released a guide outlining the steps clinicians should take to taper patients off of opioid prescriptions without causing patients harm.

Judges in 3 states block Trump admin's 'public charge' rule

Federal judges in three states on Friday temporarily blocked a final rule issued by the Trump administration that would allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications.

Around the nation: Walmart to cover kidney transplants at Mayo under Centers of Excellence program

Kidney transplants for Walmart beneficiaries will take place at multiple Mayo Clinic sites across the country, in today's bite-sized hospital and health industry news from Arkansas, California, and New Jersey.

America's biggest public health crisis, according to 4 former US surgeons general

The number of dementia cases in the United States is 'exploding,' but the country has yet to come up with a plan to tackle the condition, a group of former U.S. surgeons general write for the Orlando Sentinel—and they offer ways the nation can address the crisis.

If your DNA test reveals you're at risk of an untreatable condition, would you want to know?

As DNA sequencing becomes more common, providers face a dilemma over how much information they should reveal to their patients about their risks for untreatable conditions.

Weekly review: Why this year's flu season could be a doozy

The best (and worst) states for aging, according to U.S. News; the four "elephants in the room" hindering health care's drive toward value; and more.